Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 14/20 | 0.51 |
| ▸ | ABCG2 | Q9UNQ0 | 13/20 | 0.51 |
| ▸ | ABCC1 | P33527 | 13/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | MET | P08581 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL527316 | 1.00 | ABCB1 (0.51) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL1685990 | 0.88 | ALOX5 (0.49) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL647485 | 0.85 | KDM4E (0.52) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL646615 | 0.85 | KDM4E (0.52) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL6139815 | 0.83 | LMNA (0.43) | ABCB1ABCG2ABCC1ALDH1A1LMNA | |
| SCHEMBL645500 | 0.83 | ABCB1 (0.56) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL9440564 | 0.82 | ABCB1 (0.58) | ABCB1ABCG2ABCC1ALOX5 | |
| SCHEMBL16240911 | 0.81 | KDM4E (0.50) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL16240912 | 0.81 | KDM4E (0.50) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL9119693 | 0.80 | KDM4E (0.51) | ABCB1ABCG2ABCC1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9227351-A | — | — | None | — | — | JP | disclosed |
| EP-4655366-A1 | A FRAGRANCE COMPOSITION | Symrise AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| US-20250326984-A1 | FRAGRANCES WITH CYCLOPROPYL STRUCTURE | SYMRISE AG (DE) | 2025-10-23 | — | — | US | disclosed |
| EP-4602141-A1 | A FRAGRANCE MIXTURE (VI) | Symrise AG (DE) | 2025-08-20 | — | — | EP | disclosed |
| US-20250195384-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2025-06-19 | — | — | US | disclosed |
| WO-2025051340-A1 | TRPM8 MODULATORS AND RELATED METHOD FOR MODULATING TRPM8 RECEPTORS | SYMRISE AG (DE) | 2025-03-13 | — | — | WO | disclosed |
| EP-4519403-A1 | A FRAGRANCE MIXTURE (V) | Symrise AG (DE) | 2025-03-12 | — | — | EP | disclosed |
| EP-4516284-A1 | COSMETIC | Shiseido Company, Ltd. (JP) | 2025-03-05 | — | — | EP | disclosed |
| EP-3547990-B1 | SUNSCREEN COMPOSITION COMPRISING NANOCRYSTALLINE CELLULOSE | ANOMERA INC (CA) | 2025-02-19 | — | — | EP | disclosed |
| EP-4472606-A1 | COMPOSITIONS (III) | Symrise AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| US-6544966-B1 | Administering a lysophospholipid having one C14-22 fatty acid ester derived from soybeans; used in the fields of cosmetics and dermatology. | SHISEIDO COMPANY, LTD. (JP) | 2003-04-08 | — | — | US | disclosed |
| EP-1281396-A2 | Skin vitalizing composition for external use anti-aging preparation | SHISEIDO COMPANY LIMITED (JP) | 2003-02-05 | — | — | EP | disclosed |
| US-20020045941-A1 | Artificial skin and method for evaluating UV screening agent by use of the same | SHISEIDO COMPANY, LTD. | 2002-04-18 | — | — | US | disclosed |
| EP-1156074-A1 | Artificial skin and method for evaluating uv screening agent | Shiseido Co., Ltd. (JP) | 2001-11-21 | — | — | EP | disclosed |
| EP-1145707-A1 | COMPOSITIONS FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 2001-10-17 | — | — | EP | disclosed |
| EP-0688559-B1 | Skin anti-ageing composition | SHISEIDO CO LTD (JP) | 2001-06-20 | — | — | EP | disclosed |
| EP-1066816-A1 | AGENTS PROMOTING LAMININ PRODUCTION IN SKIN CELLS | SHISEIDO COMPANY LIMITED (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-6077520-A | ANTI-AGING TOPICAL COMPOSITION INCLUDING AT LEAST ONE OF SULFONYLETHYLENEAMINE OR MERCAPTOSULFONYLETHYLENEAMINE COMPOUNDS OF GIVEN FORMULA AND SPECIFIED ULTRAVIOLET LIGHT PROTECTIVE AGENTS | SHISEIDO COMPANY, LTD. (JP) | 2000-06-20 | — | — | US | disclosed |
| JP-H09227351-A | UV RAYS ABSORBING SKIN COSMETIC | SHISEIDO CO LTD | 1997-09-02 | — | — | JP | disclosed |
| EP-0688559-A1 | Skin anti-ageing composition | SHISEIDO COMPANY LIMITED (JP) | 1995-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326984-A1 | FRAGRANCES WITH CYCLOPROPYL STRUCTURE | CBR3, CNR1, CBR1 | ABCB1 2188/4885ABCG2 3174/4885ABCC1 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.